Programmable and multiparameter DNA-based logic platform for cancer recognition and targeted therapy.

Area of Science:

• Biotechnology
• Nanotechnology
• Molecular Biology

Background:

• Diseased cell surfaces, particularly cancer cells, present unique molecular markers crucial for diagnosis and treatment.
• Advancements in identifying cancer marker panels enable multi-marker analysis for improved accuracy.
• Current diagnostic tools may lack the specificity and multiplexing capability for complex cancer profiling.

Purpose of the Study:

• To design and demonstrate a DNA-based device for autonomous, logic-based analysis of multiple cancer cell-surface markers.
• To integrate DNA aptamers and strand displacement reactions for programmable cancer profiling.
• To enable simultaneous diagnostic signaling and targeted therapy delivery based on marker combinations.

Main Methods:

• Utilized DNA aptamers for specific recognition of cell-surface cancer markers.
• Employed toehold-mediated strand displacement reactions to construct modular Boolean logic gates (AND, OR, NOT).
• Assembled logic gates into a programmable DNA-based device for executing higher-order analysis of multiple markers.

Main Results:

• Successfully developed a DNA device capable of autonomous, logic-based analysis of two or three cancer cell-surface markers.
• Demonstrated the programmable assembly of modular logic gates for complex marker profiling.
• Showcased the device's potential for both diagnostic signal reporting and targeted photodynamic therapy delivery.

Conclusions:

• The developed DNA-based device offers a novel approach for precise, multi-marker cancer cell analysis.
• DNA nanotechnology holds significant potential for advancing targeted disease diagnosis and therapeutic strategies.
• This platform facilitates programmable and higher-order profiling of coexisting cell-surface markers for personalized medicine.